A Study of Onartuzumab in Combination With mFOLFOX6 in Participants With Metastatic HER2-Negative and MET-Positive Gastroesophageal Cancer
Clinical trial NCT01662869 · COMPLETED
Trial details
- NCT number
- NCT01662869
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-11-01
- Primary completion
- 2015-12-01
- Enrollment
- 564
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.